Published in Cancer Weekly, June 5th, 2006
"Ginsenoside Rh-2, a panoxadiol saponins, possesses various antitumour properties. Cyclophosphamide, an alkylating agent, has been shown to possess various genotoxic and carcinogenic effects, however, it is still used extensively as an antitumour agent and immunosuppressant in the clinic," researchers in the People's Republic of China reported.
"Previous reports reveal that cyclophosphamide is involved in some secondary neoplasmas," explained Z.H. Wang and colleagues, Lanzhou University. "In this study, the antitumour activity and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.